Ginkgolide J
CAS No. 107438-79-9
Ginkgolide J( 7-beta-Hydroxyginkgolide A | BN 52024 )
Catalog No. M20162 CAS No. 107438-79-9
Ginkgolide J has neuroprotective activity it can prevent A beta(1-42) induced inhibition of long-term potentiation in the CA1 region of mouse hippocampal slices.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 198 | In Stock |
|
| 10MG | 293 | In Stock |
|
| 25MG | 493 | In Stock |
|
| 50MG | 709 | In Stock |
|
| 100MG | 972 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGinkgolide J
-
NoteResearch use only, not for human use.
-
Brief DescriptionGinkgolide J has neuroprotective activity it can prevent A beta(1-42) induced inhibition of long-term potentiation in the CA1 region of mouse hippocampal slices.
-
DescriptionGinkgolide J has neuroprotective activity it can prevent A beta(1-42) induced inhibition of long-term potentiation in the CA1 region of mouse hippocampal slices.
-
In Vitro——
-
In VivoGinkgolide J (100 μM) treatment reduces the apoptotic damage induced by serum deprivation (24h) or treatment with Staurosporine (200 nM, 24h) in cultured chick embryonic neurons.
-
Synonyms7-beta-Hydroxyginkgolide A | BN 52024
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number107438-79-9
-
Formula Weight424.4
-
Molecular FormulaC20H24O10
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESC[C@@H]1C(=O)O[C@H]2C[C@]34[C@@H]5OC(=O)[C@]3(O[C@@H]3OC(=O)[C@H](O)[C@]43[C@@H]([C@H]5O)C(C)(C)C)[C@@]12O
-
Chemical Name7-beta-Hydroxyginkgolide A
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Vitolo O Gong B Cao Z et al. Protection against β-amyloid induced abnormal synaptic function and cell death by Ginkgolide J[J]. Neurobiology of Aging 2009 30(2):257-265.
molnova catalog
related products
-
Enpp-1-IN-16
Enpp-1-IN-16 is an inhibitor targeting ENPP1 with potential anti-cancer activity.Enpp-1-IN-16 can be used to study insulin resistance in relation to type II diabetes mellitus and various ENPP1-mediated diseases in the chondrocalcinosis and osteoarthritis classes.
-
Dovramilast
Dovramilast (CC-11050) is an orally active phosphodiesterase 4 (PDE4) inhibitor that reduces the production of pro-inflammatory mediators and cytokines.
-
Carbazeran
Carbazeran is an inhibitor of PDE2 and PDE3 and can be used for studies about metabolic diseases. Carbazeran shows inotropic and chronotropic effects in vivo(EC50 = 100 μM).
Cart
sales@molnova.com